News
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of psychiatric and ...
5-Year U.S. Treasury Note Continuous Contract $108.258 0.156 0.14% 10-Year U.S. Treasury Note Continuous Contract $110.844 0.156 0.14% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback